Martin Brenner
Förmögenhet: 36 169 $ per 2026-09-30
Förmögenhet: 36 169 $ per 2026-09-30
Dr. Martin B. Brenner is a Director, Chief Executive & Scientific Officer at iBio, Inc. He is on the Board of Directors at iBio, Inc. Dr. Brenner was previously employed as a Chief Scientific Officer & Senior Vice President by The Pelican, Inc., a Chief Scientific Officer by Recursion Pharmaceuticals, Inc., a VP & Head-Research & Early Development by ASOTHERA PHARMAECUTICALS INC, an Executive Director-Diabetes & NASH by Merck Research Laboratories Massachusetts LLC, a Senior Director & Head-BioScience by AstraZeneca PLC, and a Head-Insulin Resistance Group by Pfizer Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IBIO, INC. 0,09 % | 2026-09-01 | 30 652 ( 0,09 % ) | 36 169 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| IBIO, INC. | Verkställande Direktör | 2023-01-20 |
| Företag | Position | Slut |
|---|---|---|
| PFENEX INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-10-01 |
| RECURSION PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-01-01 |
| STOKE THERAPEUTICS, INC. | Företagsledare/Principal | 2017-01-01 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Direktör/Styrelseledamot | 2016-01-01 |
| ASTRAZENECA PLC | Företagsledare/Principal | 2013-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Pelican Inc
Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
The University of Veterinary Medicine Hanover
The University of Veterinary Medicine Hanover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån